MedDataX Logo

Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease

NCT ID: NCT03536091

Last Updated: 2019-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-01

Study Completion Date

2018-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators aim to evaluate the ability of i-scan OE together with magnification endoscopy to detect and assess microscopic inflammation in patients with inflammator bowel diseases (IBD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD)

NCT01524120

Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
WITHDRAWN

Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)

NCT01289366

Crohn´s Disease Ulcerative Colitis
COMPLETED

Endomicroscopy in IBD Patients

NCT01417728

Crohn's Disease Ulcerative Colitis
COMPLETED

Endomicroscopy for Assessment of Mucosal Healing

NCT01417715

Crohn´s Disease Ulcerative Colitis
COMPLETED

A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination

NCT04849936

Inflammatory Bowel Diseases
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study the investigators aim to evaluate the ability of i-scan OE together with magnification endoscopy to detect and assess microscopic inflammation in patients with inflammator bowel diseases. For this purpose, IBD patients will be prospectively enrolled and inflammatory changes will be assessed using optical magnification endoscopy in conjunction with optical chromoendoscopy. Endoscopic scoring of inflammatory changes in IBD patients will be done on a newly developed magnification score resulting as a consensus from experts in optical diagnosis and endoscopy in IBD patients. Results will be correlated against histopathology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnification endoscopy

All IBD patients will undergo magnification endoscopy with 136-fold optical magnification in conjunction with optical chromoendoscopy

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with established diagnosis of Inflammatory Bowel Diseases
* Ability to provide written informed consent
* Age 18 years and older

Exclusion Criteria

* poor bowel preparation
* inability to provide written informed consent
* minors
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Erlangen-Nürnberg Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Timo Rath

Professor of Endoscopy and Molecular Imaging

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Erlangen

Erlangen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EREN IBD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
NCT00587210 COMPLETED
Endomicroscopy and Crohn´s Disease
NCT01102855 COMPLETED
Chromoendoscopy for Ulcerative Colitis Surveillance
NCT00274209 COMPLETED
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 COMPLETED
The Gut Virome as a Trigger for IBD: From Metagenomics to Pathogenesis
NCT05906680 UNKNOWN
Endoscopy for Assessment of Mucosal Healing in IBD
NCT01417702 COMPLETED
Magnetic Resonance Enterography in Inflammatory Bowel Diseases
NCT04324632 UNKNOWN
Immunological Profiles in Inflammatory Bowel Disease
NCT03366090 UNKNOWN
Endomicroscopy in Ulcerative Colitis
NCT00659867 TERMINATED NA
Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients
NCT05713409 UNKNOWN
Responsiveness of Endoscopic Evaluation in UC
NCT01960439 COMPLETED
CLE for Differential Diagnosis of IBD
NCT02238665 COMPLETED
Remote Monitoring of IBD
NCT05886322 UNKNOWN
Anal Manometry Examination in Patients With Ulcerative Colitis
NCT05488041 UNKNOWN NA
The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease
NCT02481687 TERMINATED
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
NCT03841045 UNKNOWN
The Role of High-resolution Anorectal Manometry in the Diagnosis of Functional Anorectal Disorders in Patients With Inactive Inflammatory Bowel Disease
NCT05351034 UNKNOWN NA
Contrast-enhanced Bowel Ultrasound in Making a Diagnosis and Follow-up of Patients With Inflammatory Bowel Disease
NCT03744130 UNKNOWN NA
Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography
NCT04650867 COMPLETED
Clinical Study on the Distribution of Digestive Tract Microbiota Before and After Ileocecal Resection in Crohn's Disease
NCT05615116 UNKNOWN
Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease
NCT01505842 UNKNOWN NA
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 UNKNOWN
Quantitative Assessment of Intestinal Motility on Bowel Ultrasound in Patients With Inflammatory Bowel Disease: a Feasibility, Observational, Cross-sectional, Monocentric Study
NCT05719402 UNKNOWN
Confocal Endomicroscopy During Endoscopy
NCT00988273 COMPLETED
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
NCT02622139 COMPLETED NA